For most, there is little doubt that the War on Drugs is an indisputable failure. It has taken an excessive amount of money, manpower, and lives with little to show for it besides one of the worst drug epidemics in the history of the country. Time has proven these policies to be ineffective and costly, so where do we go from here?
Perspective in our nation changes and the stigma attached to addiction is now being to be confronted. Along with it all comes waves of new proposals on how America’s drug policies can evolve. Which is the right way is still unclear.
Right now, while many are confused if Jeff Sessions and the Trump administration will be actively cracking down on marijuana in states with legalization laws, there are others on the federal level that are actively pushing in the opposite direction. Part of a new bill currently in the House is trying to do even more to end the War on Drugs, by directly pushing pro-pot politics.
The Marijuana Justice Act
Last August, Democratic Senator Cory Booker from New Jersey introduced the “Marijuana Justice Act of 2017”. He was joined by Democratic Representative Barbara Lee from California in bringing the reform legislation to both chambers of Congress. Historically, this was the first time a companion legislation was introduced in both chambers to remove marijuana from the Controlled Substances Act (CSA). According to early reports, as a companion to Booker’s S. 1689 is the companion bill HR 4815. These efforts are to:
- Remove marijuana from CSA
- Incentivize states to mitigate existing and ongoing racial disparities in state-level marijuana arrests
- Expunge federal convictions specific to marijuana possession
- Allow individuals currently in federal prison for marijuana-related violations to petition for resentencing
- Create community reinvestment fund to invest in communities most impacted by the War on Drugs
Currently, marijuana is in the same federal category as drugs like:
Even those who do not advocate for marijuana legalization at least see the fault in its scheduling. Trey Growdy, the Republican Representative from South Carolina has repeatedly questioned why marijuana is considered a schedule 1 drug. This schedule actually puts it above Cocaine and methamphetamines.
One of the big pieces of the bill is also that bit about expunging convictions. Justin Strekal, political director for NORML (the National Organization for the Reform of Marijuana Laws) notes that this is “the first piece of legislation that addresses expungement issues,” to clean up former criminal records for cannabis use.
Now, a new version of the bill has been introduced to the House just last week. The goal is described as a campaign against the current federal drug policy and the failed War on Drugs.
Speaking with Sponsors of Bill
Last year, after introducing his version of the bill, Senator Cory Booker stated,
“Our country’s drug laws are badly broken and need to be fixed.”
“They don’t make our communities any safer—instead they divert critical resources from fighting violent crimes, tear families apart, unfairly impact low-income communities and communities of color, and waste billions in taxpayer dollars each year.”
Booker also believes getting rid of old pot-policies of the War on Drugs would help to bolster the economy. He states,
“It’s estimated that legal cannabis in the U.S. would create $40 billion in revenue and nearly a million jobs.”
“But it’s about more than that $40 billion —it’s about equality, and getting rid of the legal past that is stifling individuals’ opportunity and their future.”
One co-sponsor for the bill is Representative Ro Khanna. He says that revenue from taxes on marijuana would then be allocated to funding the programs to reinvest in communities that were harmed by the anti-pot policies of the War on Drugs.
Representative Barbara Lee says,
“This legislation will end this destructive War on Drugs.”
This new bill to attack the War on Drugs also has the support of the Drug Policy Alliance. Kassandra Frederique, the New York States Director for the Drug Policy Alliance, states,
“This bill makes clear to state and local elected officials that they cannot move forward beyond prohibition without taking a serious look at the historical and ongoing impacts of drug war policies.”
Supporters of the bill continue to emphasize that this isn’t just about ending pot prohibition. They say it is also about putting forth resources to help communities recover.
Why are We Talking About This?
As a provider of innovative holistic treatment for drug and alcohol abuse, we pay attention to the way drug policy changes because we know how it impacts communities around the country. In order to provide help to those who need it, we have to be talking about these changes. If drug policies shift, we must talk about how they can affect those who struggle with substance use disorder.
It does not matter if a drug is an illicit black-market substance, or a popular legalized product, substance abuse and addiction are still possible. If marijuana reform is going to continue to grow, it is also our responsibility to bring attention to the possible risks and side effects for some who use marijuana.
If pro-pot politics are going to put marijuana in the mainstream, there should also be an effort to promote substance abuse treatment options. Looking back, if the War on Drugs taught us anything, it is that there should be a strong focus on providing treatment, not punishment. If we want to make things better, we have to offer every opportunity to help those who need it most.
Marijuana abuse can have a noticeable impact on some people’s lives, and often times it is accompanied by another form of substance abuse. Acknowledging the influence of drugs in your life and knowing when to get help can make the recovery process a life-changing journey. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
The elections held this past Tuesday may not have directly addressed the status of marijuana, but voters in multiple states did elect officials who are adamant about making legal marijuana more available.
Next Year in New Jersey
One of those states is New Jersey, who’s outgoing governor is Chris Christie, chairman of the White House commission on opioids.
Last week Democrat Phil Murphy, who made legal marijuana one of the cornerstones of his campaign, won the state over. This creates a radical change for the state. For years Chris Christie has blocked attempts to legalize cannabis, and even maintains his opposition to it while fighting to help the country get a grip on the opioid epidemic.
Phil Murphy has been pretty open about his support for marijuana legalization. According to Forbes, Murphy even talked about it during his primary night victory speech saying,
“The criminalization of marijuana has only served to clog our courts and cloud people’s futures, so we will legalize marijuana,”
“And while there are financial benefits, this is overwhelmingly about doing what is right and just.”
Apparently, it isn’t just Murphy in the state that is looking forward to pushing this legislation along. The Democratically-controlled state Senate is expecting to bring up legal marijuana as early as next year. In regards to the topic, earlier this year Senate President Stephen Sweeney said,
“We are going to have a new governor in January 2018. As soon as the governor gets situated we are all here and we intend to move quickly on it.”
Voters in Virginia
Voters in the Commonwealth of Virginia also elected an official who advocates for loosening restrictions on marijuana. Current lieutenant governor Ralph Northam is in favor of decriminalizing marijuana possession. While it may not be as liberal a stance as Murphy, it is still a big step in a lot of people’s minds. Northam writes,
“We need to change sentencing laws that disproportionately hurt people of color. One of the best ways to do this is to decriminalize marijuana. African Americans are 2.8 times more likely to be arrested for marijuana possession in Virginia.”
But it isn’t just about the individuals. Northam also points out the resources going to this issue. He has written to the Virginia State Crime Commission as part of its review of the effects of marijuana decriminalization.
“Virginia spends $67 million on marijuana enforcement—enough to open up another 13,000 pre-K spots for children,”
Again, not that he is pushing for complete legalization, but to stop stiff penalties for those with small amounts of marijuana. Northam also advocates for research into the medicinal uses of marijuana. According to Richmond Times-Dispatch, he has stated,
“As a doctor, I like to make the point to people, over 100 of the medicines that we use on a daily basis come from plants,” he said in an interview Monday. “So I think we need to be open-minded about using marijuana for medical purposes.”
He isn’t alone in Virginia either. Even the Republican state Senate leader Thomas K. Norment Jr. questioned whether or not small amounts of marijuana should remain a crime.
Marijuana in More Areas
But it isn’t just these two offices that indicate there may be more change coming for marijuana policy. In other areas around the country, there are other notable shifts that may dramatically impact marijuana policy.
77% of voters in the college town eliminated fines and court costs for possessing or growing up to 200 grams of marijuana.
In an area that includes Detroit, voters now allow cannabis businesses to operate in more areas and to stay open longer. Michigan is expected to have a marijuana legalization bill on the 2018 ballot.
Lawrence Krasner won the election for District Attorney. Krasner has been outspoken about the benefits of marijuana reform. According to Krasner,
“One of the things we see in other jurisdictions is that, where marijuana is readily available, there’s a 25% reduction in opiate/opioid overdose deaths.”
“So if Philadelphia is looking at 500 opiate/opioid overdose deaths a year, a district attorney, by choosing not to enforce against marijuana usage, can potentially save 125 lives. That’s what a district attorney should exercise his or her discretion to do.”
It seems between lightening the punishments for possession, expanding programs for legal marijuana, and electing officials that will advocate for its use, marijuana may have already seen some real change this November.
What to Remember about Legal Marijuana
It is important to note for anyone who has a history of substance use disorder that the legal status of a substance does not make it safer. You could argue that marijuana is much safer than opioids like prescription drugs or heroin. While marijuana is not as lethal concerning overdose deaths, it still should not ignore the risks.
Marijuana reform has the potential for some positive and negative outcomes. Ultimately voters will have to consider weighing the pros and cons of reform. Either way, it is important to remember that any substance, legal or not, can be addictive. While marijuana may become more accepted on a legal level, it is still unhealthy to abuse this drug. If you find yourself abusing this or any drug it is very important that you seek safe and effective treatment resources.
Because drug abuse is always destructive, marijuana abuse is no exception. If you or someone you love are struggling with substance abuse or addiction, please seek help. Regardless of whether a drug is legalized or not, losing control of your use can lead to something much worse. We want to help. You are not alone. Call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Earlier this week we talked about a story that shook things up in politics as a former DEA agent threw some serious accusations at the Big Pharma industry, Congress and a number of key officials for their involvement in policies some believe helped create the enduring opioid crisis in America. Among those accused of tipping the scales in favor of Big Pharma and stripping power away from those charged with regulating the industry was Republican Representative Tom Marino.
Of course, we know that Tom Marino was President Donald Trump’s top nominee to be the nation’s drug czar.
Now, after withdrawing from the nomination to head the White House Office of National Drug Control Policy, Tom Marino says he is proud of his role in writing a 2016 law that many critics say paved the way for the current epidemic.
The Tom Marino Factor
What kind of role did Tom Marino have in the creation of the Ensuring Patient Access and Effective Drug Enforcement Act? Why is it that so many are up in arms about the bill in the first place?
To recap- Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House. It was advertised to officials as a way to ensure that patients had access to the pain medication they needed. In a statement released by Marino’s office, he claims the law would help “facilitate a balanced solution” by ensuring access to certain medications while allowing the Drug Enforcement Administration to prevent the sale and abuse of prescription drugs.
In essence, Tom Marino was supposedly pushing for a way to let pain management patients still get the useful medications they needed, without impeding on the process of curbing abuse.
But that isn’t how everyone sees it, especially after the 60 Minutes story.
Why it Matters
According to the opposition, the bill ultimately did little else besides weaken the DEA and the government’s authority to stop companies from distributing opioids in suspicious shipments.
For years prior to the passage of the “Marino Bill” some big-time drug distributors were getting fined thousands of dollars for repeatedly ignoring DEA warnings to shut down suspicious sales of hundreds of millions of pills. These companies were racking up billions of dollars in sales while turning a blind eye to obnoxious overprescribing of dangerous drugs.
Back then the DEA was able to immediately prevent drugs from reaching the street by freezing suspicious shipments. If the DEA judged that the drugs posed an “imminent danger” to a community, they could take action to prevent the flood of powerful narcotic medications from overwhelming the area.
However, the Tom Marino bill is argued to make it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies. Now, the agency is required to demonstrate that a drug distributor’s actions represent “a substantial likelihood of an immediate threat,” which officials say is far more difficult criteria to meet. The report against the Tom Marino bill even cited internal DEA and Justice Department documents and an independent assessment by the DEA’s chief administrative law judge.
The DEA even fought the bill, according to people within the agency, but in 2015 the law gained momentum again when the Justice Department named a new chief of the DEA- Chuck Rosenberg. After some reluctance, the report on 60 Minutes that included exclusive insight from Joseph T. Rannazzisi states the DEA ultimately took a deal they did not want.
Champion for Big Pharma
Marino disputed that, calling the reports “false accusations and unfair reporting.”
Tom Marino spent years pushing versions of this bill through Congress. He argued that it was to put an overly-aggressive DEA in check and protect drug companies from what he believed was unfair or misguided federal interference. In other words, he spent a lot of time fighting for Big Pharma’s ability to send millions of pills to communities that didn’t have half the population to justify them. All because the DEA was being aggressive?
The irony here is that the same people who pushed so hard for drug distributors ability to traffic obscene among of pills without the pesky DEA would probably be the same people demanding mandatory minimums for low-level drug offenders on the streets.
And again, many are still suspicious of those involved in pushing for this kind of legislation because of their connections to Big Pharma industry. The Post reports that the drug industry worked behind the scenes with lobbyists and key members of Congress, including Tom Marino.
Some reports indicate the Big Pharma industry poured more than a million dollars into election campaigns, including Marino’s, who received nearly $100,000 in campaign contributions from political action committees supporting the drug industry.
Utah Republican Senator Orrin Hatch calls the report “complete baloney” after it gained serious momentum earlier in the week.
Why are we not surprised? Because Hatch himself has received hundreds of thousands in donations from Big Pharma companies and health contributors over the years.
Holding Big Pharma accountable for their contribution to the opioid epidemic has become an increasingly popular cause. Lawyers and politicians at all levels have been pushing to put a spotlight on the shady side of the pharmaceutical industry. Now it seems that spotlight may extend more and more to exposing the politics that allow these issues to spread.
Another crucial element to putting an end to the opioid epidemic is providing safe and effective treatment for those who need help the most. A lot of people are still out there suffering because of prescription drug abuse or other dangerous substances. But we want to help. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Ever since the true nature of the opioid epidemic in America began to come to light, and people started to see the gravity of its impact in communities across the country, there have been plenty of efforts to find out how we ever got this far. We continue to ask who should be held accountable. Was it the black market drug trade? Was it the synthetic opioids coming from overseas? How did it get this bad?
Just this past week 60 Minutes and The Washington Post joined forces to interview Joe Rannazzisi, who is said to be the most important whistleblower ever on 60 Minutes.
Joe Rannazzisi is a former agent of the Drug Enforcement Administration (DEA) who ran the Office of Diversion Control; the department in charge of regulating and investigating the pharmaceutical industry. He is a former DEA deputy assistant administrator with a law degree, and a pharmacy degree, who believes the great injustice done to the American people cannot go overlooked.
Bad Business with Big Pharma
Through this inside look with Rannazzisi, he implicates Big Pharma drug makers in willingly distributed hundreds of millions of drugs to rogue pharmacies and pain-clinics-turned-pill-mills for over two decades.
Rannazzisi believes that the Big Pharma companies, some even multi-billion, Fortune 500 companies, have contributed to the problem by ignoring the truth; that powerful prescription pain medications were being diverted from doctors, clinics and pharmacies for illicit use. In the interview, Rannazzisi calls out a number of key drug makers, including:
He also calls out the three largest drug distributors:
- Cardinal Health
Saying they control probably 85%- 90% of drugs “going downstream.”
In fact, Rannazzisi said the way pain clinics seemed to pop up overnight all over the country made the whole crack-cocaine epidemic look like nothing, saying he had never seen anything like it, adding:
“These weren’t kids slinging crack on the corner. These were professionals who were doing it. They were just drug dealers in lab coats.”
Rannazzisi says after prosecuting pain doctors and pharmacists didn’t seem to put a real dent in the problem, he knew he had to work his way up; they went after distributors.
While drug distributors tried to defend themselves saying it was all on the doctors for over-prescribing medications, Rannazzisi says they know exactly how many pills are being sent out. Under the Controlled Substances Act, these distributors are required by law to report and stop what the DEA refers to as “suspicious orders”.
So what might “suspicious orders” look like? Probably something lie unusually large and/or frequent shipments of opioids being made to a location. Kind of like what was happening all over the nation for years and years.
For example, just one pharmacy in Kermit, West Virginia ordered 9 million hydrocodone pills in just over 2 years. That’s for a town of only 392 people. That’s over 11,479 pills a person each year! Almost 1,000 pills a month! From only one of the town’s pharmacies.
DEA investigators say many drug distributors ignored the DEA requirements and shipped anyway.
DEA Fighting Back
Rannazzisi wasn’t the only DEA agent to speak up about Big Pharma’s bad business. Several other DEA veterans say they saw thousands of suspicious orders and tried to fight the growing problem. Others said they tried on multiple occasions to get these companies to fix the issue, but they did nothing.
Eventually, in 2008 the DEA was able to hit some distributors with hefty fines for filing hundreds of suspicious orders, including:
- $13.2 million fine against the country’s largest drug distributor, McKesson
- $34 million fine against second-largest distributor, Cardinal Health
The fines for drug distributors over the last 7 years add up to around $341 million.
The High Rollers
In 2011, Cardinal Health attorneys called Rannazzisi’s boss at the Justice Department, who called Rannazzisi and pressed for an explanation for his policies. Rannazzisi believes that even after they had gone after small companies hundreds of times before, as soon as they went after the Fortune 500 drug makers, their power and influence started getting in his way.
Rannazzisi says that with these massive Big Pharma empires there was now money and influence being used to pressure top lawyers at the DEA to pursue a softer approach on penalizing drug distributors who broke the rules.
Former DEA attorney Jonathan Novak noticed that shocking shift in the way these kinds of cases were handled. Stating:
“These were not cases where it was black — where it was grey… These were cases where the evidence was crystal clear that there was wrongdoing going on.”
But suddenly the higher ups started to demand more and more evidence to stall the system. Fewer cases against Big Pharma companies were being approved, and road-blocks from Novak’s bosses seemed to pop up everywhere.
Novak also said he saw a huge migration of DEA lawyers switching sides to defend the drug industry in higher paying positions.
Taking it to Congress
While drug distributors started successfully stalling the progress of cases against them from the DEA, they also began to lobby Congress to get legislation that would destroy the DEA’s power over them.
Then one day Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House that was promoted as a way to ensure that patients had access to the pain medication they needed. However, Jonathan Novak, who worked in the DEA’s legal office, claims that what the bill really did was strip the agency of its ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets.
The bill’s author… Linden Barber, a former employee of the DEA.
Congressman Tom Marino, along with Congresswoman Blackburn, later wrote the inspector general for the Justice Department, demanding that Rannazzisi be investigated for trying to quote “intimidate the United States Congress.” Even though this went nowhere, Rannazzisi was stripped of his responsibilities soon after.
Some former DEA agents believe that the Big Pharma industry not only used lobbying groups to donate money to politicians to get laws passed in their favor, but also to try and push Joe Rannazzisi out of his office.
In the end, the DEA signed off on the final version of the “Marino bill.” A senior DEA representative claiming that even though they fought to stop it, growing pressure from Congress and industry lobbyists forced them into a deal it did not want.
The bill was presented to the Senate in March of 2016.
Majority Leader Mitch McConnell introduced the legislation in the Senate.
It passed by unanimous consent with no objections and no recorded votes.
It passed the House the same way, and President Obama signed it into law.
Where Are We Now?
This whole thing reminds you of the saying- if you can’t beat em, join em.
It would seem that’s exactly what a lot of DEA agents did after fighting a losing battle against powerful Big Pharma companies.
Since it all began, the pharmaceutical industry and law firms that represent them have hired at least 46 investigators, attorneys, and supervisors from the DEA, including 32 directly from the division that regulates the drug industry.
Remember that guy Linden Barber, who authored the bill that many say stripped the DEA of the power to go after Big Pharma companies? Well 3 months ago Cardinal Health, that second-largest drug distributor we were talking about that went after Rannazzisi through his boss, hired Linden Barber as the senior vice president!
Other former DEA agents and lawyers have gone on to take up so pretty prestigious positions working for drug companies, or law firms and other organizations working in the pharmaceutical industries best interest.
Joe Rannazzisi now consults with state attorneys general who have filed suit against distributors for their role in the opioid crisis.
Oh… and let us not forget Congressman Marino, who was just nominated to become President Trump’s new drug czar.
Remarkably, there are a lot of instances of people in the DEA being influenced by pharmaceutical companies and lobbyists to stand up for drug companies instead of the tens-of-thousands of Americans dying from opioids each year. In many of these instances, the individual’s go on to get high-earning jobs defending the interests of the Big Pharma industry.
So is it a made-up conspiracy? Or are pharmaceutical companies buying their way out of trouble at every turn and pushing out people like Rannazzisi who stand up to them? Is it really that hard to believe when you connect the dots?
With an ongoing opioid epidemic doing major damage to the country, we have to acknowledge everything that has contributed to this issue. Even if we set aside the idea of placing blame, we cannot prevent it from getting worse or happening again if we don’t acknowledge what helped cause it. Every drug company, policy maker, pharmacy, crooked doctor and individual should be accountable to taking action to make things better. It starts with accepting the issue and building a foundation to recover. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
It is no secret that the devastating opioid epidemic in America is still tearing a path of despair across the country. In 2015 this ongoing public health crisis ravaged communities, causing over 52,000 drug overdose deaths and more than 33,000 opioid overdose deaths. The opioid problem was a major campaign issue during the election, and now is one of the most pressing problems we face here in the states. Yet, upon examining the recent budget proposal released by President Trump and his administration, it seems the means to try and bring the epidemic to an end are lacking to say the least.
Given the current state of affairs, it is certain that tens of thousands of people will likely die of drug overdoses under President Donald Trump’s term. Taking that into account many hoped that drug treatment would be a serious priority. However, with the first big policy document from President Trump being the 2018 budget proposal, experts believe Trump is proving that the opioid crisis is not a priority. All this after claims that Trump would “spend the money” in order to “end the opioid epidemic in America.”
If anything, some experts are saying the proposal President Trump has introduced may actually make the opioid epidemic worse. So here we will take a look at some of the pros and cons of the 2018 proposed budget.
The Pros VS the Cons
According to the Office of National Drug Control Policy (ONDCP), this new budget plan makes little effort, and in the end it may ultimately prove obsolete.
Nearly 2% increase in drug treatment spending
Pro- the ONDCP says this will amount to an estimated $200 million added to the already $10.6 billion the government already spent on treatment.
Con- the catch is this money includes the $500 million added by the 21st Century Cures Act from the Obama administration.
That essentially means without that Obama era legislation the Trump budget would have actually cut drug treatment spending. Ultimately, the cut will likely happen the year after the 2018 budget because the Cures Act money is only for 2017 and 2018.
Cuts or No Cuts?
Pros- Still, according to the ONDCP figures of the 2018 budget, technically there are no proposed cuts to overall drug treatment spending this year.
Cons- However, the proposal does suggest other cuts to public health and anti-drug programs. The ONDCP states that these other cuts in funding can completely undermine any progress.
For example, the 2018 budget proposal from President Trump does seriously cut drug prevention programs across all federal agencies by approximately 11%.
Other Big Budget Debates
Probably one of the big arguments is the potential for problems with healthcare and cuts to Medicaid, especially since President Trump repeatedly ran on the promise that he would not be cutting Medicaid.
However, reports indicate Trump also proposes a 47% cut to Medicaid over the next 10 years! People have been up in arms about the suggestion that this could potentially strip the one affordable source of health insurance from millions of Americans. Part of which is actually used for drug addiction treatments.
A 2014 study showed that Medicaid paid for ¼ of projected public and private spending for drug treatment in 2014. That equates to around 7.9 billion dollars utilized for treating drug addiction.
The new 2018 budget proposal also requests nearly $400 million worth of cuts to the Substance Abuse and Mental Health Services Administration (SAMHSA)
Mental Health Block Grants
The Trump budget requests hundreds of millions of dollars to be taken away from mental health block grants.
Beyond that, the budget calls for billions of dollars to be cut from agencies and programs that work to help address the opioid epidemic and drug addiction. Agencies with proposed cuts include:
- The National Institutes of Health (NIH)
- Centers for Disease Control and Prevention (CDC)
- Food and Drug Administration (FDA)
While these are not drug treatment providers, they are actively involved in creating opportunities and providing research in the mental health and drug treatment communities.
Too Little Too Late
Advocates for drug treatment don’t only put this on Trump. For years the federal government has taken too long to take action to fight the epidemic. Even with the Obama administration it took until 2016 to pass any major legislation. Finally the 21st Century Cures Act added $1 billion to drug treatment for 2 years, but advocates insist that the problem requires much more funding.
This makes sense, considering the overdose outbreak now kills more people than:
- Even HIV/AIDS at the peak of its outbreak
Examining the budget shows that the only significant action in the budget that would affect the epidemic is cuts in funding to important elements in the fight against the epidemic. Sadly, as far as anyone has stated, there is nothing in the budget to balance out the cuts either.
What We Know
The fundamental issue is that America needs to put a lot more resources into drug addiction prevention and drug addiction treatment. The Obama administration took some steps in 2015 and 2016 to add hundreds of millions and then another billion to fund the efforts, but experts still say that was also too little too late.
The fear now is that more needs to be done to empower the agencies that are on the front lines of the fight. More needs to be put into a compassionate response. Instead, Trump’s Attorney General Jeff Sessions is advocating for a “tough on crime” attitude and endorsing the War on Drugs that has already failed the nation time and time again.
So while there is potential, and many believe Trump has an amazing opportunity to do much more than his predecessor did to create resources for battling the opioid epidemic head-on, many see these recent steps as an indication that things might get worse before they get better.
Drug abuse and addiction is a devastating and deadly disease, and providing effective and compassionate treatment makes a lifelong difference. If you or someone you love is struggling with substance abuse or addiction, think about who you want to be working with to find a real solution. Please call toll-free now.
CALL NOW 1-800-951-6135